About
InnAVasc Medical, Inc. is a medical device company founded by Duke University surgeons and scientists, which designs and develops products for vascular access for hemodialysis. The Company's first technology is an arteriovenous graft (AVG) modification that incorporates two cannulation Pods, with low bleed technology, that are resistant to posterior and sidewall needle penetration and injury. The InnAVasc arteriovenous graft was designed to reduce the potential for adverse events and device failures associated with repeated vascular access.
Technologies
OutlookMobile FriendlyTypekitVimeoGoogle Tag ManagerRenderRemoteAI
Keywords
hemodialysis accessimmediate accessdialysis needle protectionhome hemodialysismedical equipment manufacturinghemodialysis safety devicehealthcare equipment & suppliesmedical innovationcannulation zoneshemodialysis technologybackplate technologymedical devicesinvestigational devicemedical equipment and supplies manufacturingprotective backplatesneedle injury preventioncannulation confidenceclinical trialbleeding reduction deviceclinical investigation deviceraised target zonesinvestigational vascular graftb2bdialysis accessmedical researchdialysis safetyneedle puncture protectionvascular access improvementvascular access deviceself-sealing materials
Company Information
- Employees1
- Founded2013
- Annual Revenue$12000000
- Total Funding$4582672
Location
110 Swift Ave, Durham, North Carolina, United States, 27705-4800
